Kamada (KMDA)

[midastouch017]

FDA Issues Emergency Use Of Convalescent Plasma For COVID–19 Treatment

Aniket Chatterjee

August 23, 2020 5:50pm 2 min read Comments

FDA Issues Emergency Use Of Convalescent Plasma For COVID–19 Treatment
The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency’s ongoing efforts to fight COVID-19.

The FDA was successful in determining it's reasonable to believe that COVID-19 convalescent plasma may be effective in lessening the severity or shortening the length of COVID-19 illness in some hospitalized patients.

Patients who are below the age of 80 and are not on mechanical ventilation responded positively to the plasma therapy, provided they are treated within three days of the diagnosis.

https://www.benzinga.com/general/biotech/20/08/17202394/fda-issues-emergency-use-of-convalescent-plasma-for-covid-19-treatment?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+benzinga+%28Benzinga+News+Feed%29